These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1188801)

  • 21. The importance of surfaces in contact phase reactions.
    Vroman L
    Semin Thromb Hemost; 1987 Jan; 13(1):79-85. PubMed ID: 3551077
    [No Abstract]   [Full Text] [Related]  

  • 22. Congenital deficiency of Hageman factor (clotting factor XII). Report on the first two families found in Switzerland.
    Baumann R; Straub PW
    Helv Med Acta; 1968 Nov; 34(4):313-26. PubMed ID: 5704616
    [No Abstract]   [Full Text] [Related]  

  • 23. Recent advances in the understanding of contact activation reactions.
    Griffin JH; Cochrane CG
    Semin Thromb Hemost; 1979; 5(4):254-73. PubMed ID: 386517
    [No Abstract]   [Full Text] [Related]  

  • 24. Hemostatic problems in liver surgery.
    Rö JS
    Scand J Gastroenterol Suppl; 1973; 19():71-81. PubMed ID: 4577801
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of thorium dioxide upon blood clotting and platelets. I. In vitro studies.
    Hjort PF; McGehee WG; Rapaport SI
    Thromb Diath Haemorrh; 1966 Dec; 16(3):333-53. PubMed ID: 5996663
    [No Abstract]   [Full Text] [Related]  

  • 26. Coagulation factor deficiency apparently related to the Fitzgerald trait: the first cases in Japan.
    Hayashi H; Koya H; Kitajima K; Kimura I
    Acta Med Okayama; 1978 Apr; 32(1):81-3. PubMed ID: 148837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI.
    Walsh PN; Griffin JH
    Blood; 1981 Jan; 57(1):106-18. PubMed ID: 7004531
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prothrombin activation mechanism].
    Sakuragawa N
    Nihon Rinsho; 1974 May; 32(5):901-9. PubMed ID: 4603779
    [No Abstract]   [Full Text] [Related]  

  • 29. Tachibana trait: human high molecular weight kininogen deficiency with diminished levels of prekallikrein and low molecular weight kininogen.
    Nakamura K; Iijima K; Fukuda C; Kadowaki H; Ikoma H; Oh-ishi S; Uchida Y; Katori M
    Nihon Ketsueki Gakkai Zasshi; 1985 Sep; 48(6):1473-9. PubMed ID: 3853954
    [No Abstract]   [Full Text] [Related]  

  • 30. New congenital deficiency of high molecular weight kininogen and prekallikrein (Fitzgerald trait). Study of response to DDAVP and venous occlusion.
    Vicente V; Alberca I; Gonzalez R; Alegre A; Redondo C; Moro J
    Haematologia (Budap); 1986; 19(1):41-8. PubMed ID: 3636267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The "contact system" in health and disease.
    Saito H
    Adv Intern Med; 1980; 25():217-38. PubMed ID: 6987842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemorrhagic diathesis associated with partial factor XII deficiency].
    Zywicka-Lopaciuk H; Lopaciuk S
    Acta Haematol Pol; 1972; 3(3):257-63. PubMed ID: 4649309
    [No Abstract]   [Full Text] [Related]  

  • 33. Rabbit blood coagulation factor XI. Mechanism of activation of rabbit Hageman factor (factor XII).
    Wiggins RC; Cochrane CG; Griffin JH
    Thromb Res; 1979; 15(3-4):487-95. PubMed ID: 494157
    [No Abstract]   [Full Text] [Related]  

  • 34. Surgical care of patients with hereditary disorders of blood coagulation.
    Shulman NR
    Mod Treat; 1968 Jan; 5(1):61-83. PubMed ID: 4870180
    [No Abstract]   [Full Text] [Related]  

  • 35. Prothrombin utilization in congenital coagulation deficiency states.
    Owen CA; Thompson JH
    Thromb Diath Haemorrh; 1971 Jun; 25(2):297-311. PubMed ID: 5568049
    [No Abstract]   [Full Text] [Related]  

  • 36. Kallikrein and prekallikrein levels in a large number of congenital clotting deficiencies and abnormalities.
    Patrassi GM; Martinelli S; Vianello C; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(4):644-54. PubMed ID: 6184289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fitzgerald factor: a hitherto unrecognised coagulation factor.
    Waldmann R; Abraham JP; Rebuck JW; Caldwell J; Saito H; Ratnoff OD
    Lancet; 1975 Apr; 1(7913):949-51. PubMed ID: 48123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the contact system of coagulation during therapy with high doses of recombinant IL-2: implications for septic shock.
    Hack CE; Wagstaff J; Strack van Schijndel RJ; Eerenberg AJ; Pinedo HM; Thijs LG; Nuijens JH
    Thromb Haemost; 1991 May; 65(5):497-503. PubMed ID: 1871710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships.
    Kaplan AP; Ghebrehiwet B; Silverberg M; Sealey JE
    Crit Rev Immunol; 1981 Sep; 3(1):75-93. PubMed ID: 7047077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of hemodialysis on contact group of coagulation factors, platelets, and leukocytes.
    Vaziri ND; Toohey J; Paule P; Alikhani S; Hung E
    Am J Med; 1984 Sep; 77(3):437-41. PubMed ID: 6475983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.